Health Insurance
Medicare Part D Changes 2026: Lower Drug Costs, New $2,000 Cap Explained
By the PolicyZen Team · Updated March 2026 · 8 min read
Medicare Part D — prescription drug coverage — underwent its most significant structural change in two decades as part of the Inflation Reduction Act. The infamous "donut hole" coverage gap is gone. Catastrophic coverage as a separate phase is gone. In its place: a hard $2,000 annual out-of-pocket cap on covered drug costs, effective 2025 and continuing in 2026.
Starting 2025 (and continuing in 2026): Medicare Part D now has a $2,000 annual out-of-pocket cap. Once you've spent $2,000 on covered drugs, you pay nothing for the rest of the year. The catastrophic phase (where you previously paid 5% of drug costs with no cap) has been eliminated. For beneficiaries on expensive specialty medications, this is a massive, potentially life-changing savings.
The Old Structure vs. New (2025+)
Old Part D (pre-2025):
- Deductible phase: You pay 100% until deductible is met ($545 in 2024)
- Initial coverage phase: You pay 25% copays
- Coverage gap / "donut hole": You pay 25% of brand drugs, 25% of generics after spending threshold
- Catastrophic phase: You pay 5% of drug costs — with NO annual cap
New Part D (2025+):
- Deductible phase: You pay 100% up to $590 deductible (2026)
- Initial coverage phase: You pay copays/coinsurance per plan formulary
- Hard cap: Once you've spent $2,000 out-of-pocket, coverage is 100% for the rest of the year
- Donut hole: Eliminated entirely
- Catastrophic phase: Eliminated entirely
Medicare Prescription Payment Plan (Smoothing)
New in 2025: Beneficiaries can spread the $2,000 out-of-pocket costs across the full calendar year in monthly installments instead of paying large amounts early in the year. This helps people on fixed incomes who previously had to pay thousands in January before their expensive drugs reset. Enrollment is voluntary.
Insulin Cap Continues
The $35/month insulin cap for Medicare beneficiaries (established in 2023) continues in 2026. All covered insulin products are capped at $35/month regardless of plan or formulary tier.
If you're on expensive specialty drugs, run the numbers. Under the old catastrophic structure, someone on $150,000/year in specialty drugs paid $7,500/year (5%). Under the new cap, they pay $2,000 maximum. If you or a family member is on high-cost cancer drugs, MS medications, or biologics — this change is worth understanding and confirming with your plan.
Part D Premiums May Have Risen
The $2,000 cap shifted costs from beneficiaries to drug manufacturers and Part D insurers — which may be reflected in higher premiums or formulary changes. Some plans raised premiums; others restructured their drug formularies. Shopping during open enrollment (October 15 – December 7) using Medicare's Plan Finder tool remains the best way to find the lowest total cost plan for your specific medications.
Frequently Asked Questions
What changed with Medicare Part D drug costs in 2025 and 2026?
The Inflation Reduction Act restructured Part D beginning in 2025. The catastrophic phase was eliminated and replaced with a hard $2,000 annual out-of-pocket cap on covered drugs. The coverage gap ('donut hole') was closed. In the catastrophic phase, Medicare now pays 80% of costs, significantly reducing what beneficiaries pay for expensive medications.
What is the Medicare Prescription Payment Plan?
The Medicare Prescription Payment Plan (formerly called 'smoothing') allows Part D enrollees to spread their out-of-pocket drug costs evenly across monthly payments throughout the year rather than paying large amounts upfront at the pharmacy. Enrollment is optional and can be particularly helpful for people with high drug costs early in the year.
Is there still a Medicare Part D coverage gap (donut hole) in 2026?
No. The donut hole was effectively eliminated starting in 2025 with the Inflation Reduction Act changes. The new $2,000 annual out-of-pocket cap means beneficiaries will not face the sudden increase in cost-sharing that characterized the old coverage gap structure.
How does the $2,000 Part D cap work in 2026?
Once your total out-of-pocket spending on covered Part D drugs reaches $2,000 in a calendar year, your cost-sharing for covered drugs drops to $0 for the rest of the year. This cap applies to costs you personally pay — it does not include premiums or costs for non-covered drugs. The cap resets each January 1.
Are insulin costs still capped under Medicare Part D?
Yes. The $35/month insulin cap established by the Inflation Reduction Act continues in 2026. Medicare Part D enrollees pay no more than $35 for a month's supply of covered insulin products, regardless of the plan's formulary tier. This cap applies to all Part D plans.
Know What Your Medicare Plan Covers
Upload your Medicare or Part D plan to PolicyZen. Ask about your specific drugs, your 2026 cap exposure, and what changes at $2,000.
Check My Medicare Plan →
PolicyZen